Vollmer, T L <br/><br/>
A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis.  [electronic resource] 

 -  Journal of neurology  Apr 2014 
 - 773-83 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-1459 
<br/><br/><label>Standard No.: </label>10.1007/s00415-014-7264-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Endpoint Determination<br/>Female<br/>Humans<br/>Interferon-beta--adverse effects<br/>Male<br/>Middle Aged<br/>Multiple Sclerosis--drug therapy<br/>Quinolones--adverse effects<br/>Recurrence<br/>Risk Assessment<br/>Young Adult